- Home
- CCCC vs CTRN Comparison
CCCC vs CTRN Comparison
Compare CCCC & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCCC | CTRN |
|---|---|---|
| Founded | 2015 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.7M | 460.5M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CCCC | CTRN |
|---|---|---|
| Price | $3.70 | $63.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $12.20 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 4.0M | 238.4K |
| Earning Date | 05-06-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 16.45 | ★ 112.14 |
| EPS | N/A | ★ 0.91 |
| Revenue | $35,947,000.00 | ★ $819,962,000.00 |
| Revenue This Year | N/A | $8.81 |
| Revenue Next Year | N/A | $8.35 |
| P/E Ratio | ★ N/A | $70.39 |
| Revenue Growth | 1.02 | ★ 8.88 |
| 52 Week Low | $1.69 | $28.45 |
| 52 Week High | $5.17 | $66.38 |
Technical Indicators
Market Signals| Indicator | CCCC | CTRN |
|---|---|---|
| Relative Strength Index (RSI) | 43.11 | 66.29 |
| Support Level | $2.10 | $42.10 |
| Resistance Level | $3.89 | $66.38 |
| Average True Range (ATR) | 0.37 | 2.94 |
| MACD | -0.10 | 0.33 |
| Stochastic Oscillator | 16.47 | 81.43 |
Price Performance
Historical ComparisonAbout CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
About CTRN Citi Trends Inc.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.